Alerus Financial NA Sells 203 Shares of Danaher Co. (NYSE:DHR)

Alerus Financial NA cut its holdings in Danaher Co. (NYSE:DHR) by 8.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,195 shares of the conglomerate’s stock after selling 203 shares during the period. Alerus Financial NA’s holdings in Danaher were worth $610,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. HBW Advisory Services LLC purchased a new position in Danaher during the second quarter worth $216,000. Mather Group LLC. boosted its stake in shares of Danaher by 155.8% during the 2nd quarter. Mather Group LLC. now owns 8,182 shares of the conglomerate’s stock worth $2,043,000 after purchasing an additional 4,984 shares during the period. Lynx Investment Advisory bought a new position in Danaher during the 2nd quarter valued at about $63,000. Eastover Investment Advisors LLC raised its position in Danaher by 5.0% in the 2nd quarter. Eastover Investment Advisors LLC now owns 5,455 shares of the conglomerate’s stock worth $1,311,000 after purchasing an additional 262 shares during the period. Finally, Harbor Capital Advisors Inc. lifted its stake in Danaher by 8.3% in the second quarter. Harbor Capital Advisors Inc. now owns 11,505 shares of the conglomerate’s stock worth $2,875,000 after purchasing an additional 879 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

DHR stock opened at $239.69 on Monday. Danaher Co. has a one year low of $215.68 and a one year high of $281.70. The firm has a market cap of $173.12 billion, a price-to-earnings ratio of 45.74, a PEG ratio of 4.41 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The firm has a 50-day simple moving average of $254.59 and a two-hundred day simple moving average of $259.41.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.02 earnings per share. On average, equities analysts forecast that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s payout ratio is 20.61%.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Evercore ISI upped their target price on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. TD Cowen increased their target price on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Robert W. Baird decreased their target price on Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. KeyCorp upped their price target on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Finally, Stephens reiterated an “overweight” rating and set a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.